Biotechs and startup companies make decisions early that directly impact timelines, costs, and long-term success. Getting those decisions right the first time helps avoid delays, reduce risk, and protect limited resources.
With access to trusted intelligence, your team can move faster, stay aligned, and make confident decisions at every stage of development.
As a member of the Swiss Biotech Association, your organisation is eligible for exclusive preferential rates on Citeline & Evaluate solutions, including tailored services and consulting projects to accelerate your R&D decisions.
This member‑only benefit is designed specifically for biotechs and startup companies and is available to new customers only.
Book a Call
When resources are limited and expectations are high, having the right data can make a measurable difference.
Preferential pricing is available exclusively to Swiss Biotech Association members and applies to new customers only.
Book a call to find out more.
To enable the booking feature, please enable all cookies in your browser.